FDA approves Impavido to treat tropical disease leishmaniasis
The U.S. Food and Drug Administration today approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Leishmaniasis treatment is essential for those affected by this parasitic infection, primarily transmitted by sand fly bites ...